• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物动力学在靶向药物递送中的考虑因素。

Pharmacokinetic considerations for targeted drug delivery.

机构信息

Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshidashimoadachi-cho, Sakyo-ku, Japan.

出版信息

Adv Drug Deliv Rev. 2013 Jan;65(1):139-47. doi: 10.1016/j.addr.2012.11.006. Epub 2012 Dec 29.

DOI:10.1016/j.addr.2012.11.006
PMID:23280371
Abstract

Drug delivery systems involve technology designed to maximize therapeutic efficacy of drugs by controlling their biodistribution profile. In order to optimize a function of the delivery systems, their biodistribution characteristics should be systematically understood. Pharmacokinetic analysis based on the clearance concepts provides quantitative information of the biodistribution, which can be related to physicochemical properties of the delivery system. Various delivery systems including macromolecular drug conjugates, chemically or genetically modified proteins, and particulate drug carriers have been designed and developed so far. In this article, we review physiological and pharmacokinetic implications of the delivery systems.

摘要

药物传递系统涉及旨在通过控制药物的生物分布来最大化药物疗效的技术。为了优化传递系统的功能,应该系统地了解其生物分布特征。基于清除概念的药代动力学分析提供了生物分布的定量信息,该信息可以与传递系统的物理化学性质相关。迄今为止,已经设计和开发了各种传递系统,包括大分子药物偶联物、化学或基因修饰的蛋白质和颗粒药物载体。在本文中,我们回顾了传递系统的生理和药代动力学意义。

相似文献

1
Pharmacokinetic considerations for targeted drug delivery.药物动力学在靶向药物递送中的考虑因素。
Adv Drug Deliv Rev. 2013 Jan;65(1):139-47. doi: 10.1016/j.addr.2012.11.006. Epub 2012 Dec 29.
2
Subcellular drug targeting, pharmacokinetics and bioavailability.亚细胞药物靶向、药代动力学和生物利用度。
J Drug Target. 2014 Feb;22(2):95-115. doi: 10.3109/1061186X.2013.848453. Epub 2013 Nov 5.
3
Drug delivery systems: entering the mainstream.药物递送系统:步入主流
Science. 2004 Mar 19;303(5665):1818-22. doi: 10.1126/science.1095833.
4
Cell-based drug delivery.基于细胞的药物递送。
Adv Drug Deliv Rev. 2008 Jan 14;60(2):286-95. doi: 10.1016/j.addr.2007.08.029. Epub 2007 Oct 5.
5
Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution.用于靶向给药的大分子载体系统:生物分布的药代动力学考量
Pharm Res. 1996 Jun;13(6):820-31. doi: 10.1023/a:1016084508097.
6
Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.聚合物颗粒技术用于口服药物传递和靶向给药:病理生理学视角。
Nanomedicine. 2012 Sep;8 Suppl 1:S5-20. doi: 10.1016/j.nano.2012.07.005. Epub 2012 Jul 27.
7
Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overview.药物传递系统开发中药代动力学考虑的作用:历史概述。
Adv Drug Deliv Rev. 2020;157:71-82. doi: 10.1016/j.addr.2020.06.015. Epub 2020 Jun 19.
8
The Øie-Tozer model of drug distribution and its suitability for drugs with different pharmacokinetic behavior.Øie-Tozer 药物分布模型及其对具有不同药代动力学行为的药物的适用性。
Expert Opin Drug Metab Toxicol. 2011 Oct;7(10):1233-43. doi: 10.1517/17425255.2011.613823.
9
Delivery of anticancer drugs.抗癌药物的递送
Methods Find Exp Clin Pharmacol. 1989 Jul-Aug;11(7-8):439-529.
10
Seeing is believing--visualizing drug delivery in vitro and in vivo.眼见为实——体外和体内药物递送的可视化
Adv Drug Deliv Rev. 2005 Jun 15;57(8):1085-6. doi: 10.1016/j.addr.2005.01.019.

引用本文的文献

1
An injectable gambogic acid loaded nanocomposite hydrogel enhances antitumor effect by reshaping immunosuppressive tumor microenvironment.一种负载藤黄酸的可注射纳米复合水凝胶通过重塑免疫抑制性肿瘤微环境增强抗肿瘤效果。
Mater Today Bio. 2025 Feb 24;31:101611. doi: 10.1016/j.mtbio.2025.101611. eCollection 2025 Apr.
2
Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary Care.识别患有晚期纤维化的非酒精性脂肪性肝病(MASLD)高危患者并将其与初级保健中的护理相联系。
J Gen Intern Med. 2025 Feb;40(3):629-636. doi: 10.1007/s11606-024-08955-9. Epub 2024 Jul 26.
3
Strategies to Regulate the Degradation and Clearance of Mesoporous Silica Nanoparticles: A Review.
调控介孔硅纳米颗粒降解和清除的策略:综述。
Int J Nanomedicine. 2024 Jun 13;19:5859-5878. doi: 10.2147/IJN.S451919. eCollection 2024.
4
Multi-targeted immunotherapeutics to treat B cell malignancies.多靶点免疫疗法治疗 B 细胞恶性肿瘤。
J Control Release. 2023 Jun;358:232-258. doi: 10.1016/j.jconrel.2023.04.048. Epub 2023 May 5.
5
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment.用于同时递送拉帕替尼和抗生存素小干扰RNA以治疗HER2+乳腺癌的脂质纳米颗粒制剂
Pharmaceuticals (Basel). 2022 Nov 23;15(12):1452. doi: 10.3390/ph15121452.
6
Preparation and Antiproliferative Activity Evaluation of Juglone-Loaded BSA Nanoparticles.胡桃醌负载牛血清白蛋白纳米粒的制备及其抗增殖活性评价
Adv Pharm Bull. 2022 Aug;12(4):818-827. doi: 10.34172/apb.2022.087. Epub 2022 Jan 3.
7
Extending the persistence of synthetic glycoconjugates using a serum-protein binder.利用血清蛋白结合剂延长合成糖缀合物的持久性
RSC Chem Biol. 2022 Aug 23;3(10):1260-1275. doi: 10.1039/d2cb00126h. eCollection 2022 Oct 5.
8
Applications of Nano/Micromotors for Treatment and Diagnosis in Biological Lumens.纳米/微米马达在生物腔道治疗与诊断中的应用。
Micromachines (Basel). 2022 Oct 19;13(10):1780. doi: 10.3390/mi13101780.
9
Biomaterials-Mediated Tumor Infarction Therapy.生物材料介导的肿瘤梗死治疗
Front Bioeng Biotechnol. 2022 Jun 9;10:916926. doi: 10.3389/fbioe.2022.916926. eCollection 2022.
10
Mechanistic insights into encapsulation and release of drugs in colloidal niosomal systems: biophysical aspects.胶体非离子表面活性剂囊泡系统中药物包封与释放的机制洞察:生物物理方面
RSC Adv. 2021 Oct 29;11(56):35110-35126. doi: 10.1039/d1ra06057k. eCollection 2021 Oct 28.